Search research articles
Contact Us
Filters
Showing results (41-50 of 138) with videos related to
Page
of 14
Sort By:
American Heart Journal
|
April 1, 1990
Relationship between regional myocardial blood flow and the distribution of 99mTc-sestamibi in the presence of total coronary artery occlusion
S A Mousa, J M Cooney, S J Williams
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
January 1, 1991
Acute effects of commonly used drugs in the cardiac care unit on the myocardial extraction kinetics of 99mTc-Sestamibi
S A Mousa, T R Carroll, R A Morgan
Stroke
|
April 1, 1997
Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs
S A Mousa, D X Mu, B R Lucchesi
Journal of Neuroimmunology
|
July 20, 2000
Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain
S A Mousa, H Machelska, M Schäfer, et al.
Thrombosis Research
|
June 30, 1998
Oral antiplatelet efficacy of the platelet GPIIb/IIIa antagonist, DMP754 in non-human primates
S A Mousa, J Bozarth, A Youssef, et al.
Drug News & Perspectives
|
June 24, 2003
Alpha(v)beta(3) integrin in angiogenesis and restenosis
J S Kerr, S A Mousa, A M Slee
Journal of Cardiovascular Pharmacology
|
March 1, 1992
Efficacy and safety of deferoxamine conjugated to hydroxyethyl starch
S A Mousa, R C Ritger, R D Smith
The American Journal of Medicine
|
March 1, 1994
Platelet GPIIb/IIIa antagonists: how safe is this antithrombotic approach?
S A Mousa, W F De Grado, T M Reilly
Life Sciences
|
July 7, 1986
Stabilization of methionine-enkephalin in human and rat blood
V J Aloyo, S A Mousa, G R Van Loon
The American Journal of Pathology
|
April 7, 2000
Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin
S Kim, K Bell, S A Mousa, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 138) with videos related to
Sort By:
Page
of 14
American Heart Journal
|
April 1, 1990
Relationship between regional myocardial blood flow and the distribution of 99mTc-sestamibi in the presence of total coronary artery occlusion
S A Mousa, J M Cooney, S J Williams
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
January 1, 1991
Acute effects of commonly used drugs in the cardiac care unit on the myocardial extraction kinetics of 99mTc-Sestamibi
S A Mousa, T R Carroll, R A Morgan
Stroke
|
April 1, 1997
Prevention of carotid artery thrombosis by oral platelet GPIIb/IIIa antagonist in dogs
S A Mousa, D X Mu, B R Lucchesi
Journal of Neuroimmunology
|
July 20, 2000
Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain
S A Mousa, H Machelska, M Schäfer, et al.
Thrombosis Research
|
June 30, 1998
Oral antiplatelet efficacy of the platelet GPIIb/IIIa antagonist, DMP754 in non-human primates
S A Mousa, J Bozarth, A Youssef, et al.
Drug News & Perspectives
|
June 24, 2003
Alpha(v)beta(3) integrin in angiogenesis and restenosis
J S Kerr, S A Mousa, A M Slee
Journal of Cardiovascular Pharmacology
|
March 1, 1992
Efficacy and safety of deferoxamine conjugated to hydroxyethyl starch
S A Mousa, R C Ritger, R D Smith
The American Journal of Medicine
|
March 1, 1994
Platelet GPIIb/IIIa antagonists: how safe is this antithrombotic approach?
S A Mousa, W F De Grado, T M Reilly
Life Sciences
|
July 7, 1986
Stabilization of methionine-enkephalin in human and rat blood
V J Aloyo, S A Mousa, G R Van Loon
The American Journal of Pathology
|
April 7, 2000
Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin
S Kim, K Bell, S A Mousa, et al.
Page
of 14